• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for the outcome and prognosis of multiple myeloma patients with pathological fractures undergoing percutaneous vertebroplasty.接受经皮椎体成形术的多发性骨髓瘤合并病理性骨折患者的结局和预后的危险因素。
Am J Cancer Res. 2024 Jun 15;14(6):2946-2956. doi: 10.62347/VFDM5811. eCollection 2024.
2
Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures: an evidence-based analysis.经皮椎体成形术治疗疼痛性骨质疏松性椎体压缩骨折:一项循证分析
Ont Health Technol Assess Ser. 2010;10(19):1-45. Epub 2010 Oct 1.
3
Risk-benefit ratio of percutaneous kyphoplasty and percutaneous vertebroplasty in patients with newly diagnosed multiple myeloma with vertebral fracture: a single-center retrospective study.经皮椎体后凸成形术和经皮椎体成形术治疗新发多发性骨髓瘤伴脊柱骨折患者的风险效益比:一项单中心回顾性研究。
Ann Hematol. 2023 Jun;102(6):1513-1522. doi: 10.1007/s00277-023-05202-9. Epub 2023 Mar 30.
4
Percutaneous vertebroplasty for pathological vertebral compression fractures secondary to multiple myeloma.经皮椎体成形术治疗多发性骨髓瘤所致病理性椎体压缩骨折。
Arch Orthop Trauma Surg. 2012 Jun;132(6):759-64. doi: 10.1007/s00402-012-1474-y. Epub 2012 Feb 8.
5
The variability of vertebral body volume and pain associated with osteoporotic vertebral fractures: conservative treatment versus percutaneous transpedicular vertebroplasty.椎体体积变异性与骨质疏松性椎体骨折相关疼痛:保守治疗与经皮椎弓根椎体成形术对比
Int Orthop. 2017 May;41(5):963-968. doi: 10.1007/s00264-017-3409-2. Epub 2017 Feb 4.
6
Balloon kyphoplasty: an evidence-based analysis.球囊椎体后凸成形术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2004;4(12):1-45. Epub 2004 Dec 1.
7
[A nomogram for predicting residual back pain after percutaneous vertebroplasty for osteoporotic vertebral compression fractures].[一种用于预测骨质疏松性椎体压缩骨折经皮椎体成形术后残余背痛的列线图]
Zhongguo Gu Shang. 2024 Jun 25;37(6):5535-9. doi: 10.12200/j.issn.1003-0034.20230652.
8
Risk of New Fractures in Vertebroplasty for Multiple Myeloma. A Retrospective Study.多发性骨髓瘤椎体成形术中新发骨折的风险。一项回顾性研究。
Pain Med. 2020 Nov 1;21(11):3018-3023. doi: 10.1093/pm/pnaa018.
9
Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: A Systematic Review.椎体强化术(包括椎体成形术或后凸成形术)治疗癌症相关椎体压缩骨折的系统评价
Ont Health Technol Assess Ser. 2016 May 1;16(11):1-202. eCollection 2016.
10
Vertebroplasty in patients with multiple myeloma with vertebral compression fractures: protocol for a single-blind randomised controlled trial.多发性骨髓瘤伴脊柱压缩性骨折患者椎体成形术的研究方案:一项单盲随机对照试验。
BMJ Open. 2021 Sep 6;11(9):e045854. doi: 10.1136/bmjopen-2020-045854.

引用本文的文献

1
Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis.修订后的游离轻链参考区间改善了意义未明的单克隆丙种球蛋白病的风险分层并减少了过度诊断。
Blood Cancer J. 2025 Apr 28;15(1):80. doi: 10.1038/s41408-025-01289-7.

本文引用的文献

1
FDA approves first-in-class bispecific for multiple myeloma.美国食品药品监督管理局批准首款用于多发性骨髓瘤的一流双特异性药物。
Nat Biotechnol. 2023 Sep;41(9):1180. doi: 10.1038/s41587-023-01962-x.
2
Intramedullary Nailing with and without the Use of Bone Cement for Impending and Pathologic Fractures of the Humerus in Multiple Myeloma and Metastatic Disease.多发性骨髓瘤和转移性疾病中肱骨即将发生的骨折及病理性骨折采用髓内钉固定并使用或不使用骨水泥的情况
Cancers (Basel). 2023 Jul 13;15(14):3601. doi: 10.3390/cancers15143601.
3
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma.达雷妥尤单抗、环磷酰胺、硼替佐米、来那度胺和地塞米松作为诱导和巩固治疗可改善超高风险多发性骨髓瘤的预后。
J Clin Oncol. 2023 Aug 10;41(23):3945-3955. doi: 10.1200/JCO.22.02567. Epub 2023 Jun 14.
4
Chemotherapy May Obviate Prophylactic Femoral Nail Surgery for Multiple Myeloma Patients With High Mirels' Score Lesions and Impending Pathological Hip Fracture.化疗可能使患有高米雷尔评分病变且即将发生病理性髋部骨折的多发性骨髓瘤患者无需进行预防性股骨钉手术。
Cureus. 2023 Apr 17;15(4):e37670. doi: 10.7759/cureus.37670. eCollection 2023 Apr.
5
Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma.SRSF1表达增加预示多发性骨髓瘤预后不良。
J Oncol. 2023 May 10;2023:9998927. doi: 10.1155/2023/9998927. eCollection 2023.
6
Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations.多发性骨髓瘤患者病理性胸腰椎椎体骨折的管理:多学科建议
Global Spine J. 2023 Apr;13(1_suppl):85S-93S. doi: 10.1177/21925682221143732.
7
Risk-benefit ratio of percutaneous kyphoplasty and percutaneous vertebroplasty in patients with newly diagnosed multiple myeloma with vertebral fracture: a single-center retrospective study.经皮椎体后凸成形术和经皮椎体成形术治疗新发多发性骨髓瘤伴脊柱骨折患者的风险效益比:一项单中心回顾性研究。
Ann Hematol. 2023 Jun;102(6):1513-1522. doi: 10.1007/s00277-023-05202-9. Epub 2023 Mar 30.
8
Increased expression of CEP72 predicts poor prognosis in multiple myeloma.CEP72 表达增加预示多发性骨髓瘤预后不良。
Int J Lab Hematol. 2023 Jun;45(3):317-327. doi: 10.1111/ijlh.14024. Epub 2023 Feb 13.
9
Treatment of Pathological Fracture of Radius due to Multiple Myeloma with Elastic Intramedullary Nail and Cement Augmentation: Expanding the Indications of Elastic Nails.多发性骨髓瘤所致病理性桡骨骨折的弹性髓内钉和骨水泥强化治疗:拓宽弹性钉的适应证。
J Long Term Eff Med Implants. 2023;33(2):67-70. doi: 10.1615/JLongTermEffMedImplants.2022044050.
10
A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients.纳入炎症细胞和细胞因子的新型多发性骨髓瘤诊断预后模型。
Clin Exp Med. 2023 Oct;23(6):2583-2591. doi: 10.1007/s10238-023-00992-8. Epub 2023 Jan 13.

接受经皮椎体成形术的多发性骨髓瘤合并病理性骨折患者的结局和预后的危险因素。

Risk factors for the outcome and prognosis of multiple myeloma patients with pathological fractures undergoing percutaneous vertebroplasty.

作者信息

Xu Haining, Tian Jianliang, Li Liang, Liu Fang, Ren Yuebing, Guo Guangming, Peng Qian

机构信息

Department of Orthopedics, Dongying People's Hospital 317 Dongcheng South 1st Road, Dongying District, Dongying 257091, Shandong, China.

Department of Emergency, Dongying People's Hospital 317 Dongcheng South 1st Road, Dongying District, Dongying 257091, Shandong, China.

出版信息

Am J Cancer Res. 2024 Jun 15;14(6):2946-2956. doi: 10.62347/VFDM5811. eCollection 2024.

DOI:10.62347/VFDM5811
PMID:39005668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11236776/
Abstract

This study focuses on the clinical features affecting the outcome and prognosis of multiple myeloma (MM) associated with spinal fractures. We retrospectively analyzed the clinical data of 194 MM patients with pathologic thoracic or lumbar spine fractures admitted to Dongying People's Hospital from April 2005 to February 2021. Patients were categorized into effective and ineffective groups based on post-treatment pain scores and mobility to analyze the influencing factors on the efficacy. Univariate analysis showed that age ≥60 years, number of vertebral fractures ≥2, and conservative treatment were associated with the outcomes. The number of vertebral fractures ≥2 (OR=2.198, =0.034) and conservative treatment (OR=1.685, =0.012) were identified as independent risk factors. In addition, survival curves were depicted using the Kaplan-Meier method, and independent risk factors affecting 2-year survival included efficacy (HR=17.924, <0.001), age (HR=3.544, =0.003) and International Staging System staging (HR=10.770, =0.001). Finally, we constructed a high-accuracy prognostic model for predicting 2-year survival of MM patients with pathologic fractures (AUC=0.756). In conclusion, this study identified independent risk factors affecting the outcome and survival of MM patients with morbid fractures by systematically analyzing clinical characteristics and constructing a survival prediction model, thus providing effective guideline for clinical treatment.

摘要

本研究聚焦于影响多发性骨髓瘤(MM)合并脊柱骨折患者结局及预后的临床特征。我们回顾性分析了2005年4月至2021年2月期间入住东营市人民医院的194例患有病理性胸椎或腰椎骨折的MM患者的临床资料。根据治疗后疼痛评分和活动能力将患者分为有效组和无效组,以分析疗效的影响因素。单因素分析显示,年龄≥60岁、椎体骨折数量≥2处以及保守治疗与结局相关。椎体骨折数量≥2处(OR = 2.198,P = 0.034)和保守治疗(OR = 1.685,P = 0.012)被确定为独立危险因素。此外,采用Kaplan-Meier法绘制生存曲线,影响2年生存的独立危险因素包括疗效(HR = 17.924,P < 0.001)、年龄(HR = 3.544,P = 0.003)和国际分期系统分期(HR = 10.770,P = 0.001)。最后,我们构建了一个用于预测MM病理性骨折患者两年生存率的高精度预后模型(AUC = 0.756)。总之,本研究通过系统分析临床特征并构建生存预测模型,确定了影响MM病理性骨折患者结局和生存的独立危险因素,从而为临床治疗提供了有效的指导原则。